Cargando…
Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis
There is strong evidence that stromal cells promote drug resistance of cancer. Here, we show that mesenchymal stem cells (MSCs) and carcinoma-associated fibroblasts (CAFs) desensitize ERα-positive breast cancer cells to the anti-estrogen fulvestrant. In search for the mechanism, we found that MSCs a...
Autores principales: | Leyh, Benjamin, Dittmer, Angela, Lange, Theresia, Martens, John W. M., Dittmer, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770774/ https://www.ncbi.nlm.nih.gov/pubmed/26515727 |
Ejemplares similares
-
Protein- and growth-modulatory effects of carcinoma-associated fibroblasts on breast cancer cells: Role of interleukin-6
por: Dittmer, Angela, et al.
Publicado: (2019) -
Biological effects and regulation of IGFBP5 in breast cancer
por: Dittmer, Jürgen
Publicado: (2022) -
Paracrine effects of stem cells in wound healing and cancer progression
por: DITTMER, JÜRGEN, et al.
Publicado: (2014) -
Cyclic AMP Enhances TGFβ Responses of Breast Cancer Cells by Upregulating TGFβ Receptor I Expression
por: Oerlecke, Ilka, et al.
Publicado: (2013) -
Lack of evidence for nuclear IGFBP5 in mammary epithelial cells
por: Berlato, C, et al.
Publicado: (2005)